December 20, 2022
- YOUR HEALTH: Pregnancy and Type 1 diabetes
- The Age of Teplizumab: A New Era in Type 1 Diabetes
- Childhood type 1 diabetes may be substantially underdiagnosed globally
- Revised guidelines for diabetes care
- Childhood asthma is associated with development of type 1 diabetes and inflammatory bowel diseases: a Danish nationwide registry study
- Comorbidities raise COVID-19 hospital risk for children, young adults with type 1 diabetes
- Nearly 25% of children with type 2 diabetes do not have obesity
- The role of nurses in diabetes care: challenges and opportunities
- An inclusive approach to people with disabilities in diabetes care and education
- Diabetes after SARS-CoV-2 infection
- Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
- What Are The Possibilities Of Expecting Mothers To Pass On Diabetes To Babies?
- Research brief: Organizing care for diabetes patients during the COVID-19 pandemic
- A Starting Point for Precision Medicine in Type 1 Diabetes
- Our Published Quality Improvement Research of 2022: Changing T1D Healthcare
- Glycemic Control With Insulin Barely Budged Over the Past 30 Years
- Albuminuria is More Prevalent in Type 1 Diabetes
- The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies (Full text HTML, PDF)
- Perceptions of diabetes management among adolescents with type 1 diabetes and their caregivers: development and validation of the Japanese version of the diabetes family responsibility questionnaire (Full text HTML, PDF)
- Race and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and Body Mass Index in Youth With Diabetes
- Effects of initiating insulin pump therapy in the real world: a nationwide, register-based study of adults with type 1 diabetes
- Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia
- Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology (Full text HTML, PDF)
- Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic
- Transition from pediatric to adult care for individuals with type 1 diabetes: Opportunities and Challenges
- Emotional eating and disordered eating behaviors in children and adolescents with type 1 diabetes (Full text HTML, PDF)
- Parents’ perspectives of factors affecting parent-adolescent communication about type 1 diabetes and negotiation of self-management responsibilities
- Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: the DCCT/EDIC Study
- Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes (Full text HTML, PDF)
- Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data (Full text HTML, PDF)
- Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria
- Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study (Full text HTML, PDF)
- Mapping care provision for type 1 diabetes throughout Australia: a protocol for a mixed-method study
- Childhood asthma is associated with development of type 1 diabetes and inflammatory bowel diseases: a Danish nationwide registry study (Full text HTML, PDF)
- Adolescents with type 1 diabetes vs. hybrid closed loop systems: a case series of patients’ behaviour that challenges the algorithm
- Prevalence of type 1 and type 2 diabetes in children and adolescents in Germany from 2002 to 2020: A study based on electronic health record data from the DPV registry
- Successful treatment of diabetic ketoacidosis secondary to fulminant type 1 diabetes mellitus using a closed-loop artificial pancreas in a pediatric patient
- MiniMed 780G™ in 2-6-year-old children: safety and clinical outcomes after the first 12 weeks
- Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL around spontaneous exercise sessions in adults with type 1 diabetes – a randomized cross-over trial (ULTRAFLEXI-1 study)
